Literature DB >> 6315797

Mechanisms of calcitonin induction of prolonged activation of adenylate cyclase in human cancer cells.

V P Michelangeli, D M Findlay, J M Moseley, T J Martin.   

Abstract

Four human cancer cell lines (MCF 7, T 47D, ZR 75 and BEN), each of which possess calcitonin-responsive adenylate cyclase, have been investigated. Pre-treatment of cells with calcitonin resulted in two effects on their adenylate cyclase. First, the ability of adenylate cyclase to respond to further stimulation by calcitonin was reduced. Secondly, membranes from calcitonin-preincubated cells had increased activity of adenylate cyclase compared with control membranes, the activated state not only surviving washing and cell-disrupting steps but persisting for some hours after the removal of hormone from the incubation medium. This phenomenon has therefore been termed "persistent activation" and may be peculiar to the action of calcitonin. It is dose dependent and is seen with calcitonins of various origins (sCT, hCT, pCT and [Asu1-7] eCT). When pre-bound hormone was removed from the cell surface by acid washing, adenylate cyclase activities in preincubated membranes fell towards control activities and responsiveness of the enzyme to a second challenge with calcitonin returned. Inhibitors of protein synthesis prevented full recovery from desensitization but had no effect on the return towards control of residual enzyme activity in preincubated membranes. These results are consistent with continued receptor occupancy leading to a persistent activation of adenylate cyclase until internalization of the receptor has occurred.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6315797

Source DB:  PubMed          Journal:  J Cyclic Nucleotide Protein Phosphor Res        ISSN: 0746-3898


  6 in total

Review 1.  Calcitonin and calcitonin receptors: bone and beyond.

Authors:  M Pondel
Journal:  Int J Exp Pathol       Date:  2000-12       Impact factor: 1.925

2.  Abundant calcitonin receptors in isolated rat osteoclasts. Biochemical and autoradiographic characterization.

Authors:  G C Nicholson; J M Moseley; P M Sexton; F A Mendelsohn; T J Martin
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

Review 3.  Peptides from the calcitonin genes: molecular genetics, structure and function.

Authors:  L H Breimer; I MacIntyre; M Zaidi
Journal:  Biochem J       Date:  1988-10-15       Impact factor: 3.857

4.  Mechanisms of ligand binding to the parathyroid hormone (PTH)/PTH-related protein receptor: selectivity of a modified PTH(1-15) radioligand for GalphaS-coupled receptor conformations.

Authors:  Thomas Dean; Agnes Linglart; Matthew J Mahon; Murat Bastepe; Harald Jüppner; John T Potts; Thomas J Gardella
Journal:  Mol Endocrinol       Date:  2005-12-08

5.  Agonist-dependent consequences of proline to alanine substitution in the transmembrane helices of the calcitonin receptor.

Authors:  R J Bailey; D L Hay
Journal:  Br J Pharmacol       Date:  2007-05-08       Impact factor: 8.739

6.  Prolonged calcitonin receptor signaling by salmon, but not human calcitonin, reveals ligand bias.

Authors:  Kim Vietz Andreassen; Sara Toftegaard Hjuler; Sebastian G Furness; Patrick M Sexton; Arthur Christopoulos; Olivier Nosjean; Morten Asser Karsdal; Kim Henriksen
Journal:  PLoS One       Date:  2014-03-18       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.